rofecoxib has been researched along with Edema, Pulmonary in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angioedema is a recognised side effect of rofecoxib, a cyclo-oxygenase-2 (COX-2) inhibitor." | 7.71 | Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib. ( Kumar, NP; Ramasamy, KA; Snape, J; Wild, G, 2002) |
| "Angioedema is a recognised side effect of rofecoxib, a cyclo-oxygenase-2 (COX-2) inhibitor." | 3.71 | Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib. ( Kumar, NP; Ramasamy, KA; Snape, J; Wild, G, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, NP | 1 |
| Wild, G | 1 |
| Ramasamy, KA | 1 |
| Snape, J | 1 |
1 other study available for rofecoxib and Edema, Pulmonary
| Article | Year |
|---|---|
Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib.
Topics: Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Fatal Outcome; Hemor | 2002 |